The FTC and its Seven-Year Subpoena Fight Against Boehringer Ingelheim
It has been nearly seven years since the FTC began its fight with Boehringer Ingelheim Pharmaceuticals Inc. to get documents related to Aggrenox.
Tag: Teva Pharmaceutical Industries
Teva Settles Cephalon Provigil Case for Record $1.2 Billion
In a long drawn out legal battle, the FTC has recently announced that it has reached a settlement to resolve the FTC’s antitrust lawsuit against Cephalon.